Japan, Nov. 7 -- REGENERON PHARMACEUTICALS INC has got intellectual property rights for 'ANTI-NPR1 ANTIBODIES AND USES THEREOF.' Other related details are as follows:

Application Number: JP,2024-019151

Category (FI): C12N5/10,A61P9/12,A61K39/395@N,A61P13/12,A61P29/00,C12N1/19,C12N1/21,A61P35/00,C07K16/28,C12P21/08,C12N15/13,C12N15/63@Z,C12N1/15,A61P11/06,A61P11/00,A61P9/04,A61P3/04,A61P27/06,A61P3/10,A61P7/10,A61P19/00,A61P27/02

Stage: Grant (IP right document published.)

Filing Date: Feb. 13, 2024

Publication Date: April 23, 2024

The original document can be viewed at: https://www.j-platpat.inpit.go.jp/p0100

Disclaimer: Curated by HT Syndication....